Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • boetsie
    Senior Member
    • Feb 2010
    • 245

    De novo assembly of PacBio with short Illumina data

    Hi all,

    I'm a bit stuck on assemblying a bacterial genome with PacBio and Illumina data.

    We have around 15x PacBio CLR data (average of 9kb) and 0.1x CCS data. In addition, we have some older Illumina paired-end 50bp data (100x coverage) from the GAIIx.

    My problems so far;
    - The coverage of the CCS data is too small to use for error correction with Celera Assembler.
    - The length of the Illumina reads is too small for error correction, as a size of 100bp is suggested.
    - Assemblers (like MIRA and Celera Assembler) require error corrected PacBio data, but i can't correct my data as explained above.

    Does anyone have any suggestions on how to assemble these datasets? Are there tools that do not require error corrected PacBio data, or are there tools that can error correct the PacBio data with the short Illumina dataset?

    Kind regards,
    Boetsie
  • jbingham
    Member
    • Jul 2011
    • 24

    #2
    Here are 3 approaches you can try. All require installing SMRT Analysis.

    First, with PacBio's Allora assembler, you can likely get a reasonable assembly without using the Illumina. Just feed in the PacBio long reads and CCS and see what comes out. The coverage is a bit low, but you'll make some progress at least.

    Or you can go the route of assembling the Illumina data separately, and see if you can get any larger contigs out of it. If yes, use RS_AHA_Scaffolding to join contigs with the PacBio long reads.

    Another option, even though 50bp Illumina data probably isn't long enough to reliably map for an assembly: use the RS_Allora_Assembly_EC protocol in PacBio's software, with the Illumina for EC.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      Yesterday, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:10 AM
    0 responses
    8 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    30 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    39 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    25 views
    0 reactions
    Last Post SEQadmin2  
    Working...